As part of Nutraceuticals World’s 2026 State of the Industry review, Denis Neville, CEO of CoreFX Ingredients, reviewed how expectations from regulators and consumers are pushing the nutraceutical sector toward precision and accountability. CoreFX’s new CoreNhanced Bio-Transport Technology exemplifies this evolution, applying controlled-release, pharmaceutical-grade science to nutrition for measurable improvements in absorption, stability, and efficacy.

Over the past year, the nutraceutical industry faced a maturity test. Regulation tightened, consumer expectations heightened, and scrutiny increased across the entire value chain. The FDA and FTC escalated enforcement around clinical evidence standards, signaling a shift toward more rigorous, science-based requirements focused on gold-standard clinical studies. In Europe, EFSA continues to raise the bar on claim substantiation. These shifts are elevating expectations in the industry, where credibility depends on science and marketing is built on measurable results.

At the same time, big-picture economic forces have had a major influence on the dietary supplement industry. Increased tariffs, higher shipping and transportation costs, and unpredictable supply chains have made it more expensive to operate. Those added costs have squeezed margins, making differentiation more dependent on proven performance, reliable delivery, and consistency.

Meanwhile, cultural forces are reshaping how consumers measure efficacy. The rapid adoption of GLP-1 therapies has changed public perception of what “working” looks like. It’s setting a new benchmark for tangible, measurable results. Nutraceuticals are now being held to the same expectation: proof of effect, not just promise.

Science and consumer behavior are converging around that same expectation. “Clean label” has evolved into “clean performance.” Consumers want ingredients validated by real data, supported by transparent mechanisms of action, and delivered in formats that work. Bioavailability, transparency, and clinical proof are the new trust signals.

This is where the next generation of formulation technology becomes essential and where CoreFX’s CoreNhanced, our new Bio-Transport Technology (BTT) platform, stands out. By applying biotech-inspired, pharmaceutical-grade principles to nutrients, CoreNhanced food-grade controlled-release system protects nutrients and bioactive compounds during digestion and controls when and where they are absorbed. Through precision encapsulation and targeted release, it delivers measurable improvements in stability, absorption, and bioavailability — exactly the kind of performance regulators expect and consumers now demand.

At its core, CoreNhanced represents Shielded Bio-Transport Technology which is an advanced system that protects nutrients and actives within the gastric environment to ensure they are shielded until absorption in the intestinal system. This shielding maximizes bioavailability and ensures efficacy where it matters most.

Looking ahead, the dietary supplement industry should expect higher standards and greater accountability. Regulatory bodies will continue tightening the requirements around claim substantiation, pushing ingredient suppliers and brands to invest in multiple gold standard studies. Future innovation will focus not only on what’s inside but also on how it performs, and on how nutrients are protected, released, and absorbed within the body.

As the industry evolves from clean label to clean performance, the opportunity is clear: products must work better, deliver more, and stand up to scientific scrutiny. The nutraceutical sector is advancing from wellness to precision, from promise to proof. That progress is worth celebrating and protecting.